companydata.dkBiomedica-Anpartsselskab: Financial statements 2020
CVR: 15234474
Biomedica-Anpartsselskab (CVR 15234474) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 1,975,000 and a net result of DKK 827,644 compared with DKK 1,372,614 the year before. That is a decrease of 27.5% compared with the year before. The profit margin was 41.9%. Equity amounted to DKK 916,456. The solvency ratio was 61.5%.
- Revenue
- 1,975,000 kr.
- Gross Profit
- 1,065,946 kr.
- Profit/Loss
- 827,644 kr.
- Equity
- 916,456 kr.
- Total Assets
- 1,491,287 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 2 mio. | 1.1 mio. | 828 t. | 916 t. | - |
| 2019 | 2.7 mio. | 1.7 mio. | 1.4 mio. | 107 t. | - |
| 2018 | 600 t. | 38 t. | 38 t. | -1.3 mio. | - |
| 2017 | 0 | -4 t. | -4 t. | -1.3 mio. | - |
| 2016 | 0 | -4 t. | -4 t. | -1.3 mio. | - |
How creditworthy is Biomedica-Anpartsselskab?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Biomedica-Anpartsselskab has published its annual report for 2019. Revenue came to DKK 2,725,000, and the net result was DKK 1,372,614.
About Biomedica-Anpartsselskab
Biomedica-Anpartsselskab is a Danish company of the type Anpartsselskab based in Frederiksberg C, founded in 1991. The company is registered under the industry Vikarbureauers aktiviteter og anden personaleformidling. The management consists of Lars Anders Baumbach. The company is owned by Lars Anders Baumbach. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -28,050 compared with DKK 307,277 the year before. Equity amounted to DKK 2,702,360.